FDA Approves MELOXICAM — Aurobindo Pharma Limited
Aurobindo Pharma Limited secured FDA approval for its generic Meloxicam, a once-daily NSAID oral tablet. This regulatory clearance positions the company to compete in the market for meloxicam while potentially pressuring the market for branded pain management products.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed